New Delhi [India], December 3 (ANI): A large section of India's population has "hybrid immunity" against COVID-19 and the "strong" resistance it entails is a positive factor in view of emergence of Omicron variant of the virus, a senior scientist has said.
New Delhi [India], December 3 (ANI): The Indian SARS-CoV-2 Genomics Consortium (INSACOG) has called for the administration of a COVID-19 vaccine booster dose for those who are above 40 years of age and at-risk people, informed an official statement issued by INSACOG on Monday.
Nadia (West Bengal) [India], November 28 (ANI): Following the emergence of the new coronavirus Variant of Concern 'Omicron', an expert of the National Institute of Biomedical Genomics said it is important to be alarmed and informed about the variant but there is no need to panic.
Bengaluru (Karnataka) [India], November 7 (ANI): The Bruhat Bengaluru Mahanagara Palike (BBMP) Chief Commissioner on Saturday said that sewage sampling is a new thing identified by INSACOG (Indian SARS-CoV-2 Genomics Consortium) that tells if there is an increase in COVID-19 viral load in
Coimbatore (Tamil Nadu) [India], October 6 (ANI/BusinessWire India): Health Basix, a pediatric healthcare delivery platform, announced today that it has closed the seed round of funding from marquee investors like Raj Mishra of Indea Capital, Nicola Blackwood - ex-deputy Minister for Health
New Delhi [India], October 3 (ANI): No new variant of concern (VOC) or variant of interest (VOI) of COVID-19 has emerged in the country, said Dr NK Arora, co-chair of the Indian SARS-CoV-2 Genomics Consortium (INSACOG), on Sunday.
New Delhi [India], September 30 (ANI/NewsVoir): India is witnessing a revolution in genomics, with visionary start-ups on the forefront. Bangalore-based Clevergene is one such dynamic start-up, which has set an exemplary motion to this interesting field, by massively scaling up its sequencin
New Delhi [India], September 6 (ANI): The Central government on Monday refuted the allegation that genome sequencing by the Indian SARS-CoV-2 Genomics Consortium (INSACOG) has declined sharply while adding that sample sequencing has progressively increased.
New Delhi [India], July 19 (ANI): The current vaccines available in India are effective against the COVID-19 Delta variant as per the studies done by the Indian Council of Medical Research (ICMR), says Dr N K Arora, co-chair, Indian SARS-CoV-2 Genomics Consortium (INSACOG).
New Delhi [India], July 19 (ANI): The COVID-19 Delta variant is around 40-60 per cent more transmissible than Alpha Variant, revealed Dr NK Arora, Co-Chair, Indian SARS-CoV-2 Genomics Consortium (INSACOG).
New Delhi [India], July 7 (ANI): The Indian SARS-CoV-2 Genomics Consortium (INSACOG) is a national multi-agency consortium of Genome Sequencing Laboratories laboratories established by the Government of India on December 30, 2020.
New Delhi [India], June 25 (ANI): Delta Plus or AY.1 will always remain a variant of concern (VoC) as it is mutated from the Delta variant (B.1.617.2), which is also a VoC, informed the Institute of Genomics and Integrative Biology (IGIB) on Friday.